Posted: December 11, 2019
Vassiliki Papadimitrakopoulou, MD, has left The University of Texas MD Anderson Cancer Center, where she was a professor of medicine in the Department of Thoracic/Head and Neck Medical Oncology, to join Pfizer Oncology as the Clinical Development Leader. Dr. Papadimitrakopoulou is also a member of the FDA’s Oncologic Drugs Advisory Committee and was co-principal investigator of the Master Lung Protocol Study.
